CTOs on the Move

The Ritedose Corporation,

www.ritedose.com

 
  MANUFACTURING Philosophy The TRC team understands that the actions required to be a successful pharmaceutical manufacturer are more than just completing repetitive and highly detailed tasks accurately; it is the understanding that we...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ritedose.com
  • 1, Technology Circle
    Columbia, SC USA 29203
  • Phone: 803.806.3300

Executives

Name Title Contact Details

Similar Companies

Qualyst

Qualyst is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Slayback Pharma

Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. Slayback has created a unique portfolio of complex generics by smart product selection and execution and connecting various dots through a network of contract R&D laboratories and manufacturing organizations, comprising smart and rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies.

Osco Drug

Osco Drug is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neurogastrx

We are a specialty pharmaceutical company developing transformative therapies to advance the treatment of gastrointestinal (GI) disorders. We focus on developing treatments for GI disorders for which meaningful therapeutic innovation is required to satisfy unmet patient need and disease burden. Our management team and board of directors are comprised of professionals with extensive backgrounds in drug research and development, commercialization, finance and business development for leading global pharmaceutical companies and growth-stage biopharmaceutical companies. Our scientific advisory board consists of well-known gastroenterologists and clinical thought leaders. Today, our pipeline consists of two unique clinical stage therapies with the potential to bring benefit to millions of patients with chronic and debilitating GI disorders that are not adequately controlled.

ABL Medical

ABL Medical, LLC